Call Options

18 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$64.0 - $116.06 $32,000 - $58,030
500 Added 1.93%
26,400 $1.77 Million
Q2 2024

Aug 14, 2024

BUY
$110.31 - $140.45 $1.36 Million - $1.73 Million
12,300 Added 90.44%
25,900 $2.94 Million
Q1 2024

May 01, 2024

SELL
$114.22 - $140.1 $1.17 Million - $1.43 Million
-10,200 Reduced 42.86%
13,600 $1.89 Million
Q4 2023

Feb 12, 2024

BUY
$75.49 - $124.16 $928,526 - $1.53 Million
12,300 Added 106.96%
23,800 $2.95 Million
Q3 2023

Nov 13, 2023

BUY
$86.06 - $137.93 $111,878 - $179,309
1,300 Added 12.75%
11,500 $1.07 Million
Q2 2023

Aug 10, 2023

BUY
$112.47 - $130.98 $56,235 - $65,489
500 Added 5.15%
10,200 $1.31 Million
Q1 2023

May 09, 2023

BUY
$104.0 - $122.92 $218,400 - $258,132
2,100 Added 27.63%
9,700 $1.13 Million
Q4 2022

Feb 10, 2023

BUY
$84.98 - $122.67 $178,458 - $257,607
2,100 Added 38.18%
7,600 $860,000
Q3 2022

Nov 10, 2022

SELL
$76.35 - $94.18 $1.18 Million - $1.45 Million
-15,400 Reduced 73.68%
5,500 $443,000
Q2 2022

Aug 15, 2022

BUY
$67.99 - $132.89 $945,060 - $1.85 Million
13,900 Added 198.57%
20,900 $1.56 Million
Q1 2022

May 13, 2022

SELL
$94.08 - $130.2 $592,704 - $820,259
-6,300 Reduced 47.37%
7,000 $3.58 Million
Q4 2021

Feb 11, 2022

SELL
$129.87 - $162.82 $12,987 - $16,282
-100 Reduced 0.75%
13,300 $7.14 Million
Q3 2021

Nov 15, 2021

SELL
$106.71 - $143.18 $10,671 - $14,318
-100 Reduced 0.74%
13,400 $1.83 Million
Q2 2021

Aug 16, 2021

BUY
$80.99 - $107.93 $105,287 - $140,309
1,300 Added 10.66%
13,500 $1.44 Million
Q1 2021

May 17, 2021

BUY
$84.79 - $104.74 $449,387 - $555,122
5,300 Added 76.81%
12,200 $4.39 Million
Q4 2020

Feb 16, 2021

BUY
$78.0 - $104.5 $31,200 - $41,800
400 Added 6.15%
6,900 $2.55 Million
Q3 2020

Nov 16, 2020

BUY
$95.51 - $112.95 $57,306 - $67,770
600 Added 10.17%
6,500 $2.68 Million
Q2 2020

Aug 14, 2020

BUY
$62.68 - $105.34 $369,812 - $621,506
5,900 New
5,900 $2.39 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.5B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Capstone Investment Advisors, LLC Portfolio

Follow Capstone Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.